HCA Healthcare UK invests £50m in new cancer centers opening in Southwark and Chelsea

In April this year, HCA Healthcare UK, part of the world’s largest private hospital group, unveiled its £50m investment in cutting-edge cancer care, strengthening the services available across its cancer service network. The investment sees the launch of two new state-of-the-art centers; the £38.2m London Bridge Hospital, Private Care at Guy’s and the newly built £12m HCA at Sydney Street, an outpatients and diagnostics center in Chelsea. Since 2008 HCA Healthcare UK has invested £100m in cancer services and its cancer network in London, Essex and Manchester. It already provides the best quality care and treatments for cancer patients from diagnosis to surgery, chemotherapy, immunotherapy and radiotherapy, research and clinical trials and survivorship programs. The 53-bed facility London Bridge Hospital, Private Care at Guy’s hosts the UK’s first integrated robotics theatre which includes the Da Vinci robotic system, enabling surgeons to perform complex keyhole surgery for urological procedures with faster recovery times for patients. The facility at Sydney Street in Chelsea will provide a range of outpatient cancer services, including outpatient cancer treatments provided by Leaders in Oncology Care (LOC). The facility will also house a blood laboratory and aseptic pharmacy manufacturing suite and a digital PET CT scanner, one of the first in a private setting in London, to help diagnose and stage cancer earlier. Mike Neeb, CEO at HCA Healthcare UK said; “At HCA Healthcare UK we’re committed to providing the very best in expert cancer treatments with our specialist network of facilities in London, Manchester and around the UK, and we’re proud to continue and strengthen this legacy by opening two new facilities. We know that patients and their families demand the best when it comes to cancer, and we aim to offer that reassurance; that their loved ones are getting the very best care available, without delay.”